1.
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
2.
3.
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
Off-label use of orphan medicinal products: a Belgian qualitative study
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study
Reimbursement of orphan drugs in Belgium: what (else) matters?